Jonathan Oliva

Clinically Advanced p38 Inhibitors Suppress DUX4 Expression in Cellular and Animal Models of Facioscapulohumeral Muscular Dystrophy

Jonathan Oliva, Scott Galasinski, Amelia Richey et al. · Journal of Pharmacology and Experimental Therapeutics · 2019 · 89 citations · Full text

Medicine, Molecular Biology, Molecular Genetics +15

BET bromodomain inhibitors and agonists of the beta-2 adrenergic receptor identified in screens for compounds that inhibit DUX4 expression in FSHD muscle cells

Amy E. Campbell, Jonathan Oliva, Matthew Yates et al. · Skeletal Muscle · 2017 · 65 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +13

Evaluation of Aminohydantoins as a Novel Class of Antimalarial Agents

Marvin J. Meyers, Micky D. Tortorella, Jing Xu et al. · ACS Medicinal Chemistry Letters · 2013 · 41 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Inhibitors of Arg-Gly-Asp-Binding Integrins Reduce Development of Pancreatic Fibrosis in Mice

Barbara Ulmasov, Brent A. Neuschwander‐Tetri, Jinping Lai et al. · Cellular and Molecular Gastroenterology and Hepatology · 2016 · 32 citations · Full text

Life Sciences, Cell Biology, Pharmacology +15

Evaluation of spiropiperidine hydantoins as a novel class of antimalarial agents

Marvin J. Meyers, Elizabeth J. Anderson, Sarah A. McNitt et al. · Bioorganic & Medicinal Chemistry · 2015 · 30 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15